Washington, D.C. 20549
Form 8-K
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  01/09/2013
Stereotaxis, Inc.
(Exact name of registrant as specified in its charter)
Commission File Number:  000-50884
(State or other jurisdiction of
(IRS Employer
Identification No.)
4320 Forest Park Avenue, Suite 100, St. Louis, MO 63108
(Address of principal executive offices, including zip code)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01.    Other Events
On January 9, 2013, Stereotaxis, Inc. (the "Company") received notification from the NASDAQ Stock Market ("NASDAQ") that the Company had regained compliance with the minimum market value of publicly held shares requirement ("MVPHS Requirement") of $15,000,000 for a minimum of 10 consecutive business days as set forth in NASDAQ Listing Rule 5450(b)(3)(C) (the "Rule").   

Previously, on June 25, 2012, the Company received a written deficiency notice from NASDAQ advising the Company that it did not maintain a minimum MVPHS of $15,000,000 for the 30 consecutive business days prior to the date of the letter. Since, as described in the foregoing paragraph, the Company has regained compliance with the Rule, NASDAQ advised that it considers this matter to be closed.



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Stereotaxis, Inc.
Date: January 14, 2013
/s/    Karen Witte Duros

Karen Witte Duros
Sr. Vice President, General Counsel